Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial
Lopes, Renato D., MD, MHS, PhD, Alings, Marco, MD, PhD, Connolly, Stuart J., MD, Beresh, Heather, MSc, Granger, Christopher B., MD, Mazuecos, Juan Benezet, MD, Boriani, Giuseppe, MD, PhD, Nielsen, Jens C., MD, DMSc, Conen, David, MD, MPH, Hohnloser, Stefan H., MD, Mairesse, Georges H., MD, Mabo, Philippe, MD, Camm, A. John, MD, Healey, Jeffrey S., MD, MSc
Published in The American heart journal (01.07.2017)
Published in The American heart journal (01.07.2017)
Get full text
Journal Article
Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT
Kaufman, Elizabeth S., MD, FHRS, Israel, Carsten W., MD, Nair, Girish M., MBBS, Armaganijan, Luciana, MD, Divakaramenon, Syamkumar, MBBS, Mairesse, Georges H., MD, Brandes, Axel, MD, Crystal, Eugene, MD, Costantini, Otto, MD, Sandhu, Roopinder K., MD, MPH, Parkash, Ratika, MD, MSc, Connolly, Stuart J., MD, Hohnloser, Stefan H., MD, Healey, Jeff S., MD, MSc, FHRS
Published in Heart rhythm (01.08.2012)
Published in Heart rhythm (01.08.2012)
Get full text
Journal Article